MedPath

SE OF CITRATE VERSUS ACETATE BASED DIALYSATE IN HEMODIALYSIS

Phase 4
Completed
Conditions
Health Condition 1: null- ON MAINTAINANCE HEMODIALYSIS
Registration Number
CTRI/2017/05/008546
Lead Sponsor
MANIPAL UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

After approval from institutional ethics committee with informed consent, 32 stable end stage renal disease (CKD5D) patients on twice weekly maintenance hemodialysis of five hour duration in the dialysis unit of Kasturba hospital, Kasturba Medical College, Manipal University were enrolled in the study. The inclusion criteria were end stage renal disease patient on maintenance hemodialysis for minimum 3 months duration

Exclusion Criteria

Patients with intercurrent illnesses or hospital admissions in the last one month, on heparin free hemodialysis for any reason and irregular for hemodialysis sessions for the last three months were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes studied were impact of CD in comparison with AD on hemodialysis adequacy, reuse of dialyzer and quality of life. The secondary outcomes studied were effect on intradialytic hypotension, acidosis correction and episodes of symptomatic hypocalcemia.Timepoint: 1 YEAR
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes studied were effect on intradialytic hypotension, acidosis correction and episodes of symptomatic hypocalcemia.Timepoint: 1 YEAR
© Copyright 2025. All Rights Reserved by MedPath